Trevena Stock Forecast for 2023 - 2025 - 2030
Updated on 05/07/2024
Trevena Stock Forecast and Price Target
Trevena's stock is projected to advance by 555.74% from the previous closing price if it reaches the average target of $4.00 by the year's end, as reputable analysts recently projected. This potential upside is calculated on a high-end estimate of $4.00 and a low-end estimate of $4.00. If you're looking for Trevena (TRVN) stock information, you might also want to check out AcelRx Pharmaceuticals (NasdaqGM:ACRX).
555.74% Upside
Trevena Fair Value Forecast for 2023 - 2025 - 2030
Trevena's Price has increased by 100.00% In the last zero years, going from $0.00 to $0.00. In the next year, analysts expect Fair Value to reach $0.65 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
JNJ Stock Forecast | Johnson & Johnson | Outperform |
9
|
$148.72 | Buy/Sell | $174.55 | 14.31% |
PCRX Stock Forecast | Pacira BioSciences | Outperform |
16
|
$26.51 | Buy/Sell | $47.90 | 69.75% |
HRTX Stock Forecast | Heron Therapeutics | Buy |
7
|
$2.87 | Buy/Sell | $5.63 | 126.48% |
CPIX Stock Forecast | Cumberland Pharmaceuticals | - |
0
|
$2.03 | Buy/Sell | $8.50 | -100.00% |
ACRX Stock Forecast | AcelRx Pharmaceuticals | Buy |
6
|
$0.99 | Buy/Sell | $4.63 | 329.29% |
Trevena EPS Price Prediction Forecast for 2023 - 2025 - 2030
Trevena's EPS has increased by 100.00% In the last zero years, going from $0.00 to $0.00. In the next year, analysts expect EPS to reach $-0.54 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.